KALVISTA PHARMACEUTICALS INC (KALV) Stock Earnings & Estimates
USA - NASDAQ:KALV - US4834971032 - Common Stock
11.13 USD
+0.13 (+1.18%)
11.1 USD
-0.03 (-0.27%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.39M 459.33% | 16.13M 92.25% | 12.69M -21.33% | 1.19M -100.00% | 40.672M | 125.83M 209.38% | 357.82M 184.37% | 489.14M 36.70% | 602.21M 23.12% | 691.31M 14.80% | 774.18M 11.99% | |||||
| EBITDA YoY % growth | -18.53M 16.91% | -29.44M -58.88% | -40.02M -35.94% | N/A -43.38% | N/A -67.39% | N/A -14.68% | N/A -26.76% | -188.333M -34.88% | -214.465M -13.88% | -160.171M 25.32% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -18.71M 16.25% | -29.82M -59.38% | -40.53M -35.92% | -56.004M -42.91% | -99.969M -66.80% | -109.403M -14.76% | -128.253M -26.68% | -179.677M -27.93% | -197.533M -9.94% | -147.138M 25.51% | 97.359M 166.17% | 212.31M 118.07% | 308.7M 45.40% | 382.04M 23.76% | 451.96M 18.30% | |
| Operating Margin | -223.00% | -184.87% | -319.39% | -4,706.21% | N/A | N/A | N/A | N/A | -485.67% | -116.93% | 27.21% | 43.40% | 51.26% | 55.26% | 58.38% | |
| EPS YoY % growth | -1.56 | -1.41 9.67% | -1.64 -16.31% | -2.35 -46.34% | -3.52 -40.00% | -3.67 0.00% | -3.12 -1.19% | -3.61 -4.41% | -3.68 -3.66% | -1.45 60.61% | 1.44 199.56% | 3.24 124.38% | 4.15 28.03% | 4.64 11.93% | 5.06 9.12% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.03 -13.69% | -0.96 -23.21% | -0.72 27.54% | -0.73 34.43% | -0.65 36.90% | -0.51 46.93% | -0.20 71.56% |
| Revenue Q2Q % growth | 5.412M | 10.37M | 24.128M | 30.526M 2,040.67% | 19.515M 260.59% | 29.272M 182.28% | 48.788M 102.20% |
| EBITDA Q2Q % growth | -55.784M -22.98% | -51.51M -9.21% | -45.635M 17.95% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -54.612M -19.21% | -51.337M -8.62% | -39.754M 10.26% | -46.098M 21.88% | -43.086M 21.11% | -33.835M 34.09% | -13.854M 65.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | -1.12 -28.74% | -0.97 | -0.15 | -15.18% |
| Q4 2025 Q2Q % growth | -0.99 2.94% | -0.80 | -0.19 | -24.26% |
| Q3 2025 Q2Q % growth | -0.78 7.14% | -0.89 | 0.11 | 12.51% |
| Q2 2025 Q2Q % growth | -0.91 -13.75% | -0.93 | 0.02 | 1.74% |
| Q1 2025 Q2Q % growth | -0.87 -17.57% | -0.93 | 0.06 | 6.68% |
| Q4 2024 Q2Q % growth | -1.02 -32.47% | -0.75 | -0.27 | -36.67% |
| Q3 2024 Q2Q % growth | -0.84 -12.00% | -0.78 | -0.06 | -7.35% |
| Q2 2024 Q2Q % growth | -0.80 11.11% | -0.80 | 0.00 | 0.27% |
| Q1 2024 Q2Q % growth | -0.74 21.28% | -0.88 | 0.14 | 15.48% |
| Q4 2023 Q2Q % growth | -0.77 21.43% | -0.96 | 0.19 | 19.55% |
| Q3 2023 Q2Q % growth | -0.75 18.48% | -1.00 | 0.25 | 25.35% |
| Q2 2023 Q2Q % growth | -0.90 -12.50% | -1.08 | 0.18 | 16.51% |
| Q1 2023 Q2Q % growth | -0.94 -42.42% | -1.06 | 0.12 | 11.41% |
| Q4 2022 Q2Q % growth | -0.98 -50.77% | -1.11 | 0.13 | 11.58% |
| Q3 2022 Q2Q % growth | -0.92 -64.29% | -0.94 | 0.02 | 2.57% |
| Q2 2022 Q2Q % growth | -0.80 -37.93% | -0.81 | 0.01 | 0.90% |
| Q1 2022 Q2Q % growth | -0.66 -8.20% | -0.73 | 0.07 | 9.18% |
| Q4 2021 Q2Q % growth | -0.65 -75.68% | -0.57 | -0.08 | -13.77% |
| Q3 2021 Q2Q % growth | -0.56 -7.69% | -0.62 | 0.06 | 9.75% |
| Q2 2021 Q2Q % growth | -0.58 -75.76% | -0.68 | 0.10 | 15.29% |
| Q1 2021 Q2Q % growth | -0.61 -45.24% | -0.61 | 0.00 | -0.01% |
| Q4 2020 Q2Q % growth | -0.37 24.49% | -0.67 | 0.30 | 44.39% |
| Q3 2020 Q2Q % growth | -0.52 -126.09% | -0.27 | -0.25 | -95.01% |
| Q2 2020 Q2Q % growth | -0.33 -50.00% | -0.56 | 0.23 | 41.18% |
| Q1 2020 Q2Q % growth | -0.42 10.64% | -0.63 | 0.21 | 33.59% |
| Q4 2019 Q2Q % growth | -0.49 | -0.43 | -0.06 | -13.93% |
| Q3 2019 Q2Q % growth | -0.23 | -0.46 | 0.23 | 49.67% |
| Q2 2019 Q2Q % growth | -0.22 | -0.47 | 0.25 | 53.31% |
| Q1 2019 Q2Q % growth | -0.47 | -0.34 | -0.13 | -39.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 1.426M | 2.131M | -705K | -33.08% |
| Q4 2021 Q2Q % growth | -100.00% | 594.997K | -594.997K | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 874.283K | -874.283K | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 425.003K | -425.003K | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 1.224M | -1.224M | -100.00% |
| Q4 2020 Q2Q % growth | 3.82M 30.38% | 1.692M | 2.128M | 125.77% |
| Q3 2020 Q2Q % growth | 1.58M -59.38% | 11.652M | -10.072M | -86.44% |
| Q2 2020 Q2Q % growth | 3.92M -29.87% | 3.324M | 596K | 17.93% |
| Q1 2020 Q2Q % growth | 3.37M -9.41% | 3.283M | 87K | 2.65% |
| Q4 2019 Q2Q % growth | 2.93M | 4.12M | -1.19M | -28.88% |
| Q3 2019 Q2Q % growth | 3.89M | 4.331M | -441K | -10.18% |
| Q2 2019 Q2Q % growth | 5.59M | 3.813M | 1.777M | 46.60% |
| Q1 2019 Q2Q % growth | 3.72M | 3.882M | -162K | -4.17% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.77% | -37.44% | 0% | 0% |
| Revenue | 6.96% | -15.38% | N/A | N/A |